Bcl11b/CTIP2, a zinc finger transcriptional repressor, interacts with the RNApolymeraseII regulatory complex pTefb and exert an inhibitory action on it. It is also implicated in the regulation of stem cells. Genetic variations in its locus is associated with increased risk for cardiovascular disease making it relevant to study the role of Bcl11b in the heart. Using knockdown/overexpression strategies, we showed that Bcl11b overexpression leads to increased hypertrophic response while its overexpression induces opposite effects. To study its role in vivo, we will use cardiac specific knock out mice and analyse the effect on cardiac remodelling and stem cells. This study will allow us to gain further insights into the molecular mechanisms tha...
The identification of different pools of cardiac progenitor cells resident in the adult mammalian he...
SummaryPostnatal cardiac myocytes respond to diverse signals by hypertrophic growth and activation o...
Rationale: Cancer therapy can be associated with short- and long-term cardiac dysfunction. Patients ...
Bcl11b/CTIP2, a zinc finger transcriptional repressor, interacts with the RNApolymeraseII regulatory...
Inflammatory cells orchestrate post-ischemic cardiac remodeling after myocardial infarction (MI). St...
Bcl11b is a transcription factor that acts both as a transcriptional repressor and activator in a co...
Bcl11b est un facteur impliqué à la fois dans la répression et l’activation de la transcription. Une...
Transcriptional adaptation in cardiomyocytes precedes cellular deterioration and functional decline ...
In this issue of Cell, the Calmodulin binding transcription activator 2 (CAMTA2), is shown by Song e...
Heart failure is one of the leading causes of mortality in the western world and encompasses a wide ...
During life, the heart is exposed to different types of stresses. In response to changing demands or...
Cardiac hypertrophy is considered an early hallmark during the clinical course of heart failure and ...
Cardiovascular disease (CVD) is the leading cause of death worldwide. During disease progression, th...
BACKGROUND Mutations in sarcomeric and cytoskeletal proteins are a major cause of hereditary card...
AIM: The adapter protein p130Cas, encoded by the Bcar1 gene, is a key regulator of cell movement, ad...
The identification of different pools of cardiac progenitor cells resident in the adult mammalian he...
SummaryPostnatal cardiac myocytes respond to diverse signals by hypertrophic growth and activation o...
Rationale: Cancer therapy can be associated with short- and long-term cardiac dysfunction. Patients ...
Bcl11b/CTIP2, a zinc finger transcriptional repressor, interacts with the RNApolymeraseII regulatory...
Inflammatory cells orchestrate post-ischemic cardiac remodeling after myocardial infarction (MI). St...
Bcl11b is a transcription factor that acts both as a transcriptional repressor and activator in a co...
Bcl11b est un facteur impliqué à la fois dans la répression et l’activation de la transcription. Une...
Transcriptional adaptation in cardiomyocytes precedes cellular deterioration and functional decline ...
In this issue of Cell, the Calmodulin binding transcription activator 2 (CAMTA2), is shown by Song e...
Heart failure is one of the leading causes of mortality in the western world and encompasses a wide ...
During life, the heart is exposed to different types of stresses. In response to changing demands or...
Cardiac hypertrophy is considered an early hallmark during the clinical course of heart failure and ...
Cardiovascular disease (CVD) is the leading cause of death worldwide. During disease progression, th...
BACKGROUND Mutations in sarcomeric and cytoskeletal proteins are a major cause of hereditary card...
AIM: The adapter protein p130Cas, encoded by the Bcar1 gene, is a key regulator of cell movement, ad...
The identification of different pools of cardiac progenitor cells resident in the adult mammalian he...
SummaryPostnatal cardiac myocytes respond to diverse signals by hypertrophic growth and activation o...
Rationale: Cancer therapy can be associated with short- and long-term cardiac dysfunction. Patients ...